Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22996| Title: | Colorectal cancer: cetuximab, KRAS, BRAF, PIK3CA mutations and beyond |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Antibodies, Monoclonal/*therapeutic use,Antineoplastic Agents/*therapeutic use,Colorectal Neoplasms/*drug therapy/genetics/mortality/pathology,Genetic Testing,Genotype,Humans,Molecular Targeted Therapy,*Mutation,Patient Selection,Phenotype,Phosphatidylinositol 3-Kinases/*genetics,Proto-Oncogene Proteins/*genetics,Proto-Oncogene Proteins B-raf/*genetics,Treatment Outcome,ras Proteins/*genetics |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/22996 |
| ISSN: | 1747-4132 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/20932136 http://www.expert-reviews.com/doi/pdfplus/10.1586/egh.10.62 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Katsios-2010-Colorectal cancer_ c.pdf | 518.95 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
